Kairos Pharma KAPA
NYSE KAPA
$0.54 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Kairos Pharma (KAPA) Goodwill & Intangibles (2023 - 2025)

Updated

Kairos Pharma (KAPA) recorded Goodwill & Intangibles of $62,000 in Q4 2025, down 72.1% from $222,000 a year earlier.

Analysis

Kairos Pharma (KAPA) Goodwill & Intangibles (2023 - 2025) Analysis & Trends

Starting with Q4 2023, Kairos Pharma's Goodwill & Intangibles history includes 6 quarters.

  • Across earlier years, Goodwill & Intangibles came in at $222,000 in FY2024 (-41.9%) and $382,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Kairos Pharma 11.24 Mn -1.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 62,000.00
Jun 30, 2025 142,000.00
Mar 31, 2025 182,000.00
Dec 31, 2024 222,000.00
Sep 30, 2024 262,000.00
Dec 31, 2023 382,000.00
API Access

Kairos Pharma Goodwill & Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-and-intangibles&ticker=KAPA&period=max&api_key=YOUR_API_KEY